The emergence of new therapeutic targets in pulmonary arterial hypertension: from now to the near future
Explore this paper's citation graph
Summary
The goal of this report is to review the current PAH treatments, as well as novel therapies that will pave the future in this devastating disease.
- Type
- article
- Published
- 2013-02-01
- Cited by
- 13
- References
- 130
- OpenAlex
- https://openalex.org/W23362814
- Semantic Scholar
- https://api.semanticscholar.org/CorpusID:2148871
Keywords
Political science
References
- Beraprost therapy for pulmonary arterial hypertension.
- Addition of inhaled treprostinil to oral therapy for pulmonary arterial hypertension: a randomized controlled clinical trial.
- Pulmonary toxicities of tyrosine kinase inhibitors.
- Fasudil inhibits platelet-derived growth factor-induced human pulmonary artery smooth muscle cell proliferation by up-regulation of p27kip¹ via the ERK signal pathway.
- Transplantation of autologous endothelial progenitor cells may be beneficial in patients with idiopathic pulmonary arterial hypertension: a pilot randomized controlled trial.
- CD44 expression in plexiform lesions of idiopathic pulmonary arterial hypertension
- NFAT signaling: choreographing the social lives of cells.
- RhoA and Rho kinase activation in human pulmonary hypertension: role of 5-HT signaling.
- Continuous subcutaneous infusion of treprostinil, a prostacyclin analogue, in patients with pulmonary arterial hypertension: a double-blind, randomized, placebo-controlled trial.
- Imatinib in pulmonary arterial hypertension, a randomized, efficacy study (IMPRES)
- Interleukin-1 receptor antagonist treatment reduces pulmonary hypertension generated in rats by monocrotaline.
- A Randomized Clinical Trial of Aspirin and Simvastatin for Pulmonary Arterial Hypertension: ASA-STAT
- Acute vasodilator effects of inhaled fasudil, a specific Rho-kinase inhibitor, in patients with pulmonary arterial hypertension
- Differential effects of stable prostacyclin analogs on smooth muscle proliferation and cyclic AMP generation in human pulmonary artery.
- AMN107, a novel aminopyrimidine inhibitor of p190 Bcr‐Abl activation and of in vitro proliferation of Philadelphia‐positive acute lymphoblastic leukemia cells
- Molecular signature of a right heart failure program in chronic severe pulmonary hypertension.
- From oncoproteins/tumor suppressors to microRNAs, the newest therapeutic targets for pulmonary arterial hypertension
- Simvastatin as a treatment for pulmonary hypertension trial.
- Platelet-derived growth factor expression and function in idiopathic pulmonary arterial hypertension.
- Apoptosis and inhibition of the phosphatidylinositol 3-kinase/Akt signaling pathway in the anti-proliferative actions of dehydroepiandrosterone
Cited by
- Novel therapeutic approaches for pulmonary arterial hypertension: Unique molecular targets to site-specific drug delivery.
- Ranolazine Reduces Remodeling of the Right Ventricle and Provoked Arrhythmias in Rats with Pulmonary Hypertension
- Adrenomedullin alleviates pulmonary artery collagen accumulation in rats with pulmonary hypertension induced by high blood flow.
- ‘Real-life’ information on pulmonary arterial hypertension: the iPHnet Project
- Role for DNA Damage Signaling in Pulmonary Arterial Hypertension
- Discovery of spirocyclic proline tryptophan hydroxylase-1 inhibitors.
- Translating Research into Improved Patient Care in Pulmonary Arterial Hypertension
- Combination therapy in pulmonary arterial hypertension: recent accomplishments and future challenges
- Expression of key enzymes in the mevalonate pathway are altered in monocrotaline-induced pulmonary arterial hypertension in rats.
- 15-HETE protects pulmonary artery smooth muscle cells against apoptosis via SIRT1 regulation during hypoxia.
- Treatment Discontinuation or Interruption in Pulmonary Arterial Hypertension
- ErbB3 Governs Endothelial Dysfunction in Hypoxia-Induced Pulmonary Hypertension
- Oxidative Stress Influence in the Development of Pulmonary Arterial Hypertension
Related papers
No related papers recorded.